BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine,…
BOSTON andĀ ROLLE, Switzerland, Oct. 16, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced…
BOSTON, Sept. 22, 2025 /PRNewswire/ -- SOPHiA GENETICSĀ (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion…